Maryland Digital News > Blog > MARKET > Annovis Bio’s stock rockets 76% after reporting positive data in Parkinson’s disease trial MARKETAnnovis Bio’s stock rockets 76% after reporting positive data in Parkinson’s disease trialMarylandDigitalNews.comMARKETposted on Jul. 03, 2024 at 11:48 am The stock is on track for its best performance since May 21, 2021, when it gained 127%. Source link MarylandDigitalNews.comJuly 3, 2024previous articlePink Pixel 9 shows up in another video, this time it’s runningnext articleGoogle’s greenhouse gas emissions climbed nearly 50 percent in five years due to AIthe authorMarylandDigitalNews.comYou Might Also LikeMARKETSean ‘Diddy’ Combs is selling $61.5 million Beverly Hills estate that was raided by FedsSeptember 17, 2024MARKETFanDuel owner Flutter Entertainment strikes $2.6 billion deal to buy Italy’s SnaitechSeptember 17, 2024MARKETYour financial adviser keeps calling. This is why you should call them back.September 17, 2024MARKETA Dish-DirecTV deal may not improve satellite TV’s fate much, but bonds still rallySeptember 17, 2024MARKETHow Microsoft’s dividend hike and new $60 billion buyback program stack upSeptember 16, 2024MARKETWhy Intel’s latest move for its foundry business is so significantSeptember 16, 2024
MARKETSean ‘Diddy’ Combs is selling $61.5 million Beverly Hills estate that was raided by FedsSeptember 17, 2024
MARKETFanDuel owner Flutter Entertainment strikes $2.6 billion deal to buy Italy’s SnaitechSeptember 17, 2024
MARKETA Dish-DirecTV deal may not improve satellite TV’s fate much, but bonds still rallySeptember 17, 2024
